Accessibility Tools

Randal D. Chase, PhD

Randal D. Chase, PhD

Board of Directors

Dr. Chase joined the Board of Directors in March 2015.  Since 2011, Dr. Chase has served as a business advisor and consultant to companies in the life science sector.  From 2006 to 2011, he served as President and Chief Executive Officer of Immunovaccine, Inc., a clinical-stage biotechnology company developing vaccines against cancer and infectious diseases. 
Dr. Chase is also a former president of Shire Biologics, North American Vaccine, Pasteur Merieux Connaught, and Quadra Logic Technologies, Inc.  His early career was at Bristol Myers and Glaxo Pharmaceuticals.  Dr. Chase has also served as a member of the board of directors for numerous companies, and recently served as Chairman of the Board for Medicago, Inc. until its sale to Mitsubishi Tanabe Pharma Corporation in 2013. 
He currently serves as Chairman of the Board for Medimabs, Inc., a privately-held antibody company.  Dr. Chase attended the Senior Executive Program of the London Business School in the United Kingdom, which holds a bachelor of sciences degree in biochemistry from Bishop's University and a Ph.D. in biochemistry from the Unviersity of British Columbia.  Dr. Chase completed a post doctoral fellowship at the McArdle Cancer Institute of the Unversity of Wisconsin.

Register to receive email alerts for GeoVax press releases
Copyright © GeoVax 2023. All Rights Reserved.